By G HossainPosted on September 29, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The AAV pullback comes amid Biogen’s aggressive cost-cutting campaign, which put some 1,000 jobs on the chopping block with the goal of generating $1 billion in savings by 2025. Biogen Shuffles 20 Staff After Ending AAV Work Post navigation Genmab Buys Rising Cancer Star Merus for $8BGSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years